Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents
- 14 September 1993
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 241 (2-3) , 183-188
- https://doi.org/10.1016/0014-2999(93)90201-r
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Substituted cyclic imides as potential anti-gout agentsLife Sciences, 1990
- Oxypurinol as an inhibitor of xanthine oxidase-catalyzed production of superoxide radicalBiochemical Pharmacology, 1988
- Use and abuse of allopurinol.BMJ, 1987
- Asymptomatic hyperuricemia. Risks and consequences in the normative aging studyThe American Journal of Medicine, 1987
- Clinical Pharmacokinetics of AllopurinolClinical Pharmacokinetics, 1986
- Inhibitory action of quercetin on xanthine oxidase and xanthine dehydrogenase activityPharmacological Research Communications, 1985
- Severe allopurinol toxicityThe American Journal of Medicine, 1984
- Inhibition of urate production by allopurinolBiochemical Pharmacology, 1977
- Formation of nucleotides of [6-14C]allopurinol and [6-14C]oxipurinol in rat tissues and effects on uridine nucleotide poolsBiochemical Pharmacology, 1973
- THE RENAL EXCRETION OF URIC ACID IN PATIENTS WITH GOUT AND IN NONGOUTY SUBJECTS *†Journal of Clinical Investigation, 1959